After Every trading session you Get the next day's healthcare stock pick Predicted to give you Over 5% day trading range opportunity.
Previous downward trend close: $27.06
9/4/2019 Forcast high: $28.16
Low: $26.29
Price opportunity zone: $1.87 (6.9%)
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in San Diego, California. On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.